title: [Antidepressants in cardiology].
abstract: Amitriptyline was for a long time the sole medication for the management of depression in cardiological patients despite a large number of side effects. It was substituted by the safe and cardiologically neutral sertraline, a selective serotonin re-uptake inhibitor. Presently the results of agomnelatine therapy of cardiovascular diseases and accompanying depressions arise great interest.
authors.forename: A M
authors.initials: AM
authors.lastname: Kotov
authors.forename: A D
authors.initials: AD
authors.lastname: Stotsky
authors.forename: D B
authors.initials: DB
authors.lastname: Kolesnikov
mesh_terms: D000081:Acetamides / Q000009:adverse effects / Q000627:therapeutic use; D000639:Amitriptyline / Q000009:adverse effects / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000150:complications* / Q000503:physiopathology; D003863:Depression / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D020280:Sertraline / Q000009:adverse effects / Q000627:therapeutic use; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D000639:Amitriptyline; D000928:Antidepressive Agents; D020280:Sertraline; C084711:agomelatine; D009281:Naphthalenes